A benign form of neuromyelitis optica does it exist?

Archives of Neurology

Volumn 68, Issue 7, 2011, Pages 918-924

  Collongues, Nicolas ^a   Cabre, Philippe ^g   Marignier, Romain ^b   Zéphir, Hèléne ^c   Papeix, Caroline ^d   Audoin, Bertrand ^e   Lebrun Frenay, Christine ^f   Pelletier, Jean ^e   Fontaine, Bertrand ^d   Vermersch, Patrick ^c   Confavreux, Christian ^b   De Seze, Jérôme ^a   Brassat, David ^h   Brochet, Bruno ^h   Camdessanche, Jean Philippe ^h   Camu, William ^h   Casez, Olivier ^h   Castelnovo, Giovanni ^h   Clanet, Michel ^h   Clavelou, Pierre ^h   Cotton, François ^h   Creange, Alain ^h   Defer, Gilles ^h   Debouverie, Marc ^h   Edan, Gilles ^h   Gout, Olivier ^h   Jousserand, Guillemette ^h   Kirschen, Philippe ^h   Labauge, Pierre ^h   Laplaud, David ^h   Moreau, Thibault ^h   Rumbach, Lucien ^h   Stankoff, Bruno ^h   Tourbah, Ayman ^h   Vukusic, Sandra ^h   Olivier, Anne ^h   Borgel, Florent ^h   Coustans, Marc ^h   Grimaud, Jérome ^h   Hautecoeur, Patrick ^h   Heinzlef, Olivier ^h   Le Page, Emmanuelle ^h   Mekies, Claude ^h   Pittion, Sophie ^h   Seeldrayers, Pierrette ^h   Slassi, Ilham ^h   Wiertlevski, Sandrine ^h   more..

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE LYON   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e University of Aix Marseille   (France)

^f PASTEUR HOSPITAL   (France)

^g Centre Hospitalier et Universitaire de Fort de France   (France)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLATIRAMER; INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISABILITY SEVERITY; ETHNICITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; FRANCE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OPTIC NEURITIS; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RECURRENCE RISK; REMISSION; RETROSPECTIVE STUDY;

EID: 79960170311     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.127     Document Type: Article

References (24)

1. Cabre P, González-Quevedo A, Bonnan M, et al. Relapsing neuromyelitis optica: long term history and clinical predictors of death. J Neurol Neurosurg Psychiatry. 2009;80(10):1162-1164.
2. Collongues N, Marignier R, Zéphir H, et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology. 2010;74(9):736-742.
3. Ghezzi A, Bergamaschi R, Martinelli V, et al; Italian Devic's Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol. 2004;251(1):47-52. (Pubitemid 38210489)
4. Rivera JF, Kurtzke JF, Booth VJ, Corona T. Characteristics of Devic's disease (neuromyelitis optica) in Mexico. J Neurol. 2008;255(5):710-715.
5. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology. 2003;60(5):848-853. (Pubitemid 36297372)
6. Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007;114(4):810-815.
7. Bergamaschi R, Jarius S, Robotti M, Pichiecchio A, Wildemann B, Meola G. Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol. 2009;256(12):2097-2099.
8. Köller H, Neuen-Jacob E, Saleh A, Kieseier BC, Jander S, Hartung HP. A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12 years: MRI follow up and histological findings. J Neurol. 2006;253(6):819-820. (Pubitemid 43980160)
9. Miranda de Sousa A, Puccioni-Sohler M, Dias Borges A, Fernandes Adorno L, Papais Alvarenga M, Papais Alvarenga RM. Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child. J Infect Chemother. 2006;12(6):396-398. (Pubitemid 46147386)
10. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489. (Pubitemid 43958540)
11. Sahraian MA, Moinfar Z, Khorramnia S, Ebrahim MM. Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients. Eur J Neurol. 2010;17(6):794-799.
12. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European Database for Multiple Sclerosis. J Neurol Neurosurg Psychiatry. 1992;55(8):671-676.
13. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988;38(2):180-185. (Pubitemid 18036832)
14. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997;120(pt 11):2059-2069. (Pubitemid 27493740)
15. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-2112. (Pubitemid 39626806)
16. Marignier R, de Sèze J, Vukusic S, et al. NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler. 2008;14(4):440-445. (Pubitemid 351943855)
17. Marignier R, Nicolle A, Watrin C, et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain. 2010;133(9):2578-2591.
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33(11):1444-1452. (Pubitemid 14237132)
19. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007;68(8):603-605.
20. Cañellas AR, Gols AR, Izquierdo JR, Subirana MT, Gairin XM. Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology. 2007;49(5):393-409. (Pubitemid 46951325)
21. Cassinotto C, Deramond H, Olindo S, Aveillan M, Smadja D, Cabre P. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neuroradiol. 2009;36(4):199-205.
22. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008;131(pt 11):3072-3080.
23. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114. (Pubitemid 29442132)
24. Langer-Gould A, Popat RA, Huang SM, et al. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol. 2006;63(12):1686-1691. (Pubitemid 44925075)